Manufacturer record
Smith & Kenner Pharmaceuticals Pvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Smith & Kenner Pharmaceuticals Pvt.Ltd (Telangana) were declared Not of Standard Quality between November 2024 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: A004, Azithromycin Oral Suspension (exp Nov 2025). State Lab, Drugs Control Laboratory, Telangana (state lab) found it not of standard quality: The label of the drug should be mentioned as Azithromycin Oral suspension IP. But the letters IP is not mentioned on the label. Listed in the May 2025 alert.
Records by type
2 records linked to Smith & Kenner Pharmaceuticals Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Azithromycin Oral Suspension | Batch A004Mfg Dec 2023 · Exp Nov 2025 | The label of the drug should be mentioned as Azithromycin Oral suspension IP. But the letters IP is not mentioned on the labelLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab | May 2025 |
| Divalproex Sodium Tablets IP 500 mg | Batch D2306Mfg Dec 2023 · Exp Nov 2026 | NOT OF STANDARD QUALITY 1. The coating is not uniform and rough surface is observed on the whole tablet, hence description does not complies as per IP. 2. The dissolution test parameter doees not complies as per manufacturing method of analysis, hence the drug Divalproex sodium is of Not of Standard Quality with respect to Description and Dissolution test parameter.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab | Nov 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.